Total Raised

$258.73M

Investors Count

21

Deal Terms

12

Funding, Valuation & Revenue

14 Fundings

TransMedics has raised $258.73M over 14 rounds.

TransMedics's latest funding round was a IPO for $91.2M on May 2, 2019.

TransMedics's latest post-money valuation is from May 2019.

Sign up for a free demo to see TransMedics's valuations in May 2019 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

5/2/2019

IPO

$91.2M

$XXM

$X.XXB

((X.XXx))

FY XXXX

2

7/12/2016

Growth Equity - II

$12.5M

$XXM

0

FY undefined

1

5/26/2016

Growth Equity

$51.2M

$XXM

0

FY undefined

4

9/21/2015

Unattributed

$XXM

$XXM

0

FY undefined

10

6/4/2015

Series F

$XXM

$XXM

0

FY undefined

10

Date

5/2/2019

7/12/2016

5/26/2016

9/21/2015

6/4/2015

Round

IPO

Growth Equity - II

Growth Equity

Unattributed

Series F

Amount

$91.2M

$12.5M

$51.2M

$XXM

$XXM

Investors

Valuation

$XXM

$XXM

$XXM

$XXM

$XXM

Revenue

$X.XXB

((X.XXx))

FY XXXX

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

2

1

4

10

10

Start free trial
New call-to-action

TransMedics Deal Terms

12 Deal Terms

TransMedics's deal structure is available for 12 funding rounds, including their IPO from May 02, 2019.

Round

IPO

Growth Equity - II

Growth Equity

Unattributed

Series F

Funding Date

$XXM

$XXM

$XXM

$XXM

$XXM

Pre-Money Valuation

$XXM

$XXM

$XXM

$XXM

$XXM

Post-Money Valuation

$XXM

$XXM

$XXM

$XXM

$XXM

Amount Raised

$XXM

$XXM

$XXM

$XXM

$XXM

Shares Authorized

Issuance Price

$XXM

$XXM

$XXM

$XXM

Dividend Rate

$XXM

$XXM

$XXM

$XXM

Liquidation Preferences

$XXM

$XXM

$XXM

$XXM

Liquidation Price

Participation

Conversion Price

Anti Dilution

$XXM

$XXM

$XXM

$XXM

General Voting

$XXM

$XXM

$XXM

$XXM

$XXM

Board Voting

$XXM

$XXM

$XXM

$XXM

$XXM

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

IPO

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

Growth Equity - II

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

Growth Equity

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

Unattributed

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

Series F

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

TransMedics Investors

21 Investors

TransMedics has 21 investors. Flagship Pioneering invested in TransMedics's Growth Equity - II funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

6/22/2000

7/12/2016

10
Series A, Series B (2004), Series B - II (2006), Series C (2007), Series D (2010), Series D - II (2011), Series E (2012), Series F (2015), Growth Equity (2016), Growth Equity - II (2016)

Venture Capital

Massachusetts

6/22/2000

7/12/2016

7
Series A, Series D (2010), Series D - II (2011), Series E (2012), Series F (2015), Growth Equity (2016), Growth Equity - II (2016)

Venture Capital

California

11/21/2012

7/12/2016

3
Series E, Growth Equity (2016), Growth Equity - II (2016)

David Abrams, and Travis Rhodes

Private Equity

Massachusetts

00/00/0000

00/00/0000

Lung Biotechnology

Subscribe to see more

Corporation

Maryland

00/00/0000

00/00/0000

Palm Beach Capital

Subscribe to see more

Private Equity

Florida

First funding

6/22/2000

6/22/2000

11/21/2012

00/00/0000

00/00/0000

Last Funding

7/12/2016

7/12/2016

7/12/2016

00/00/0000

00/00/0000

Investor

Lung Biotechnology

Palm Beach Capital

Rounds

10
Series A, Series B (2004), Series B - II (2006), Series C (2007), Series D (2010), Series D - II (2011), Series E (2012), Series F (2015), Growth Equity (2016), Growth Equity - II (2016)
7
Series A, Series D (2010), Series D - II (2011), Series E (2012), Series F (2015), Growth Equity (2016), Growth Equity - II (2016)
3
Series E, Growth Equity (2016), Growth Equity - II (2016)

Subscribe to see more

Subscribe to see more

Board Seats

David Abrams, and Travis Rhodes

Type

Venture Capital

Venture Capital

Private Equity

Corporation

Private Equity

Location

Massachusetts

California

Massachusetts

Maryland

Florida

TransMedics Acquisitions

3 Acquisitions

TransMedics acquired 3 companies. Their latest acquisition was Summit Aviation on August 16, 2023.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

8/16/2023

$XXM

Acquired

2

8/2/2023

Subscribe to see more

$XXM

Subscribe to see more

10

8/1/2023

Subscribe to see more

$XXM

Subscribe to see more

10

Date

8/16/2023

8/2/2023

8/1/2023

Investment Stage

Companies

Subscribe to see more

Subscribe to see more

Valuation

$XXM

$XXM

$XXM

Total Funding

Note

Acquired

Subscribe to see more

Subscribe to see more

Sources

2

10

10

New call-to-action

Compare TransMedics to Competitors

G-Level Logo
G-Level

G-Level is an online retailer that sells clothing, accessories, footwear, and home decor items. The company serves a customer base that includes both men and women. It is based in Hasselt, Belgium.

C Change Biosciences Logo
C Change Biosciences

C Change Biosciences specializes in surgical support technology for the medical sector, focusing on infection prevention and workflow efficiency. The company offers automated systems for producing and maintaining sterile slush, essential for organ preservation during surgeries, and provides sealed containers that protect against airborne contaminants. These products are primarily used in operating rooms and by clinical teams during complex surgical procedures. It was founded in 2004 and is based in Winston-Salem, North Carolina.

V
Verimetra

Verimetra aims to make medical instruments "smart" and manufacturers miniature thin film sensors used in medical applications that involve very small high end catheters. The Company designs and manufactures sensors using micro-electromechanical systems (MEMS) technology, which is the only method available that produces sensors small enough to be embedded in surgical devices without changing their basic form or function, allowing the company's customers to sell the same products, now "smart", without requiring the surgeon to use a new device. Verimetra aims to make medical devices "smart" by embedding (US Patent 6,494,882) a variety of small sensors at an place on or within the device. Simply stated, the company make "dumb" metal tools "smart". Examples include forceps, grippers, retractors, drills, and other surgical devices. Through the use of Verimetra's products, medical device manufacturers are able to deliver features and functionality that, depending on the medical procedure, improve outcomes, reduce risk and shorten patient recovery times. Verimetra's new product features are also used by manufacturers to strengthen their market position, enter new markets and maintain gross margins. Verimetra aims to give these manufacturers a way to accomplish these goals by adding features at a low cost without product redesign. Furthermore, in many instances, Verimetra's customers' goals will be met by the transformation of a re-usable product (one-time sale) into a smart disposable product (one sale per procedure).

C
CoRepair

CoRepair, Inc. is developing a radiofrequency (RF) device system for the treatment of congestive heart failure.

Cardiola Logo
Cardiola

Cardiola have designed a patented device, the m.pulse device designed to treat chronic heart failure (CHF), non-surgically, in a patient's home.

N
NeoChord

NeoChord focuses on beating heart mitral valve repair within the healthcare sector. The company offers the neochord artificial chordae delivery system, an echo-guided treatment for mitral valve regurgitation. It provides consultation services and resources for patients and healthcare professionals. NeoChord was formerly known as mValve. It was founded in 2007 and is based in Osseo, Minnesota.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.